Versor Investments LP Decreases Stake in Genpact Limited (NYSE:G)

Versor Investments LP reduced its stake in shares of Genpact Limited (NYSE:G) by 60.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,000 shares of the business services provider’s stock after selling 9,082 shares during the quarter. Versor Investments LP’s holdings in Genpact were worth $258,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. SRH Advisors LLC purchased a new position in Genpact in the 4th quarter worth $26,000. Manchester Capital Management LLC acquired a new position in shares of Genpact in the fourth quarter valued at about $38,000. UMB Bank n.a. raised its stake in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Venturi Wealth Management LLC lifted its holdings in shares of Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider’s stock worth $103,000 after purchasing an additional 1,121 shares during the period. Finally, Versant Capital Management Inc boosted its position in Genpact by 17.0% in the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider’s stock valued at $136,000 after buying an additional 461 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Genpact

In other news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by insiders.

Genpact Stock Performance

Shares of Genpact stock opened at $52.69 on Tuesday. The firm has a market cap of $9.29 billion, a PE ratio of 18.55, a price-to-earnings-growth ratio of 1.84 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76. The business’s fifty day simple moving average is $48.00 and its 200-day simple moving average is $43.46.

Genpact (NYSE:G) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Equities analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.29%. This is a boost from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio (DPR) is presently 23.94%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on G. Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Robert W. Baird raised their target price on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $60.00 in a report on Friday, February 7th. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and increased their price target for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Mizuho boosted their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $48.44.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.